Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Edgewise Therapeutics ( (EWTX) ) just unveiled an update.
On January 8, 2025, Edgewise Therapeutics announced the promotion of Behrad Derakhshan to Chief Operating Officer. Previously the Chief Business Officer, Dr. Derakhshan’s extensive experience in business development within the biotechnology sector is expected to strengthen Edgewise’s operational leadership.
More about Edgewise Therapeutics
Edgewise Therapeutics is a biotechnology company focused on developing treatments for rare diseases.
YTD Price Performance: 1.33%
Average Trading Volume: 802,407
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $2.59B
See more insights into EWTX stock on TipRanks’ Stock Analysis page.
